Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Alopecia patients have less GPER-1, which might affect hair loss.

PRP and cell therapies may help with hair loss, but more research is needed.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Understanding Polycystic Ovary Syndrome (PCOS) and its causes can lead to effective treatments.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

New treatment using engineered nanovesicles in hydrogel improves hair growth by repairing hair follicle cells in a mouse model of hair loss.

Human hair follicle stem cells can turn into multiple cell types but lose some of this ability after being grown in the lab for a long time.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

Testosterone is key for male sexual function, and treating hormone imbalances can improve sexual issues.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Human skin acts like a hormone-producing organ, making and managing various hormones important for skin and hair health.

Early treatment of PCOS in teens is crucial to prevent long-term health issues like diabetes and heart disease.

Men with androgenetic alopecia have oilier and less hydrated scalps, especially in sensitive areas.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Fulvestrant solution doesn't help hair loss in men and postmenopausal women.

Androgens may block hair growth signals, targeting this could treat hair loss.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.